abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
1101: Mitochondria M2 Antibody (IgG), EIA Print View
Mitochondria M2 Ab (IgG) EIA  < 20.1  Units 

PRIMARY
1 Serum 1 (0.3) mL   Room Temperature - 7 Day(s)/Refrigerated - 14 Day(s)/Frozen - 30 Day(s)  
ALTERNATE

Anti-Mitochondrial antibodies (AMA) have been reported in greater than 90% of patients with Primary Biliary Cirrhosis (PBC). AMA are also occasionally found in patients with chronic active hepatitis, cryptogenic cirrhosis and in patients with clinical but no biochemical evidence of liver disease. The M2 type of AMA is strongly associated with PBC.

Preferred: Red top (no gel)

Acceptable: Serum Separator Tube
Setup Schedule
Tuesday, Thursday, Saturday

Reported (Analytical Time)
Same day

CPT Code
83520

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
The MIT3 antigen used for detection of anti-mitochondria M2 antibodies contains immunodominant epitopes of the E2 subunits of the pyruvate dehydrogenase complex (PDC-E2), the branched-chain 2-oxo-acid dehydrogenase complex (BCOADC-E2), and the 2-oxo glutarate dehydrogenase complex (OGDC-E2). Reference - Moteki, S. et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 1996; 24:97-103.






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database